EMEA-000551-PIP04-21-M01
Key facts
| Active substance |
Givinostat
|
| Therapeutic area |
Neurology
|
| Decision number |
P/0513/2022
|
| PIP number |
EMEA-000551-PIP04-21-M01
|
| Pharmaceutical form(s) |
Oral suspension
|
| Condition(s) / indication(s) |
Treatment of Duchenne muscular dystrophy
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Italfarmaco S.p.A.
E-mail: ITFPIP@italfarmacogroup.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|